An official website of the United States government
Home
Name
Belotecan
Alternate Names
CKD-602
Abbreviations
None
Category
Chemotherapy
Subcategory
Topoisomerase Inhibitor
NSC Number
None
Primary Site
None
Histology
None
Remarks
Belotecan is currently being studied in the treatment of non small cell lung cancer (NSCLC) and uterine cancer. These trials are currently limited to Korea. Code as "Other" treatment until FDA approval for treatment of cancers in the United States.
Coding
This drug should be coded
